Apr 8, 2020
In this episode, Therese Markow and Dr. Ben Albensi discuss the different types of dementia (now officially known as neurocognitive disorders) as we currently know them. With almost 50 million cases worldwide, and a new diagnosis every 3 seconds, it is important that we know what we can do to identify, treat, and potentially even slow down dementia – all of which are discussed in this episode. It has only been in the last couple of years that the amount of funding for dementia and Alzheimer’s research has increased, though it is still lower than the research funding for cancer and heart disease related research. It is vital that we all do what we can to create a dementia-friendly community and support the research being done to help us learn more about the differences of the types of dementia, the differences between the sexes and races, and other information currently being studied that we are still learning about.
Key Takeaways:
"Like we learned in cancer therapy, we need to treat different types of Alzheimer's disease or dementia differently. I think that we're going to have an improvement in the effectiveness of these drugs once you're able to discriminate the type of dementia people have more accurately and also earlier." — Dr. Ben Albensi
Connect with Dr. Ben Albensi:
Hôpital St-Boniface Hospital Profile: Dr. Benedict C. Albensi
Email: balbensi@sbrc.ca
Cell Phone: 973-668-0206
LinkedIn: Benedict C. Albensi, PhD, BCMAS, CRQM
Twitter: @balbensi & @albensiconsult
Connect with Therese:
Website: www.criticallyspeaking.net
Twitter: @CritiSpeak
Email: theresemarkow@criticallyspeaking.net
Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it.